Bitget Introduces Major App Upgrade, Unifying Crypto, Stocks, Onchain, and TradFi Markets in a Unified Interface for 120 Million Users
Notified -
Globe Newswire26-12-2025, 17:00
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00